BeNeLux Partnership

Regenerative Medicine Expansion in the BeNeLux Region

We are pleased to announce an exciting development for Regen Lab in the BeNeLux region.

To enhance our presence and ensure optimal service, we have established a new distribution network in collaboration with esteemed partners: DEN Medical, Vivacy Netherlands, and BeMedico.

Effective immediately, these are the only authorized organizations permitted to distribute Regen Lab products in the BeNeLux region.

Distributors Informations

VivacyNetherlands : the aesthetic market in both the Netherlands and Belgium.

Main contact person:
North of the Netherlands,
Charlotte Warmink : warmink@vivacy.nl

South of the Netherlands,
Joelle Bakermans : j.bakermans@vivacy.nl

Dutch speaking part of Belgium,
Sofie Lannoy : s.lannoy@vivacy.be

French speaking part of Belgium,
Kathleen Segers : k.segers@vivacy.be

BeMedico : the musculoskeletal market in Belgium.

Main contact person:
Dominique Soetaert : info@bemedico.be

DEN Medical : exclusive partner for musculoskeletal market in the Netherlands.

Main contact person:
Roel de Ruiter : rderuiter@denmedical.nl

Regen Lab will continue to directly serve Luxembourg.

Main contact person:
Maxime Habran : adv.france@regenlab.com

We look forward to strengthening our partnerships and continuing to provide high-quality regenerative medicine solutions.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More